Bunkerhill ECG-EF vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS

AI Verdict

Bunkerhill ECG-EF is a software-only AI algorithm designed to analyze existing 12-lead ECGs for reduced left ventricular ejection fraction, aiding in early heart failure risk identification. In contrast, the Verily Study Watch is a wearable device that collects real-time physiological data, including single-channel ECGs for irregular pulse and AFib detection, primarily for remote monitoring and clinical research. While both leverage AI and ECG data in cardiology, they serve different purposes: one for retrospective analysis of clinical data and the other for active data collection and remote patient insights.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is to rapidly screen a broad patient population for early signs of reduced left ventricular ejection fraction (LVEF) using existing 12-lead ECG data. This tool is ideal for integrating into automated clinical workflows within EHRs to identify patients at risk for heart failure efficiently and non-invasively.

View Bunkerhill ECG-EF →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch if you require continuous, unobtrusive physiological data collection and irregular pulse monitoring for specific patients, particularly for clinical research or remote management of conditions like atrial fibrillation. This prescription-only wearable is best suited for detailed, long-term data acquisition and analysis beyond a single point-in-time diagnostic test.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF Study Watch with Irregular Pulse Monitor (Home)
Pricing Contact sales for pricing details. Unknown
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. Unknown
FDA Status Yes AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill ECG-EF

Bunkerhill ECG-EF is a software-only solution designed for seamless integration with existing EHRs and clinical archives, supporting automated workflows with minimal disruption to clinical practice. In contrast, the Verily Study Watch is a wearable device that requires patient compliance for wearing and potentially interacting with the device, which can introduce additional management overhead for clinicians.

Clinical Value

Tie

Both tools offer significant and FDA-cleared clinical value for critical cardiac conditions. Bunkerhill ECG-EF aids in the early identification of heart failure risk by detecting reduced LVEF from routine ECGs, leveraging existing data. The Verily Study Watch provides continuous monitoring and on-demand ECG for AFib detection, along with multi-sensor data collection that can also contribute to heart failure risk identification through activity data. Their distinct focuses address different, yet equally important, clinical needs.

Pricing & Value

Tie

Neither Bunkerhill ECG-EF nor the Verily Study Watch provides public pricing information, both requiring direct contact for details. Without transparent pricing or publicly available cost-effectiveness studies for either tool, it is not possible to definitively determine which offers better value.

Enterprise Readiness

Bunkerhill ECG-EF

Bunkerhill ECG-EF is a software-only solution designed for seamless integration with existing EHRs and clinical archives, supporting automated workflows and explicitly stating HIPAA compliance and BAA availability. The Verily Study Watch, while having BAA and FDA clearance, involves managing physical devices and patient compliance, and the mention of a past HIPAA lawsuit, even if resolved, could be a point of concern for enterprise adoption.

Innovation

Bunkerhill ECG-EF

While both are innovative, Bunkerhill ECG-EF, as part of the broader Carebricks platform, demonstrates a more expansive and adaptable approach to AI innovation. It leverages existing, routine data (ECGs, CTs, EHR notes) to derive new, critical insights and automate complex workflows across multiple specialties, including using generative AI for clinical reasoning and action. The Verily Study Watch is innovative in its wearable form factor and multi-sensor data collection, but its primary focus remains on data acquisition for research and specific monitoring.

Support & Docs

Study Watch with Irregular Pulse Monitor (Home)

Verily provides more explicit documentation and support resources, including user manuals and regulatory information specifically for the Study Watch, readily available online. While Bunkerhill Health offers contact information and case studies, Verily's public-facing support and documentation appear more comprehensive for its device.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF Study Watch with Irregular Pulse Monitor (Home)
Name Bunkerhill ECG-EF Study Watch with Irregular Pulse Monitor (Home)
Company BunkerHill Health Verily Life Sciences LLC
Description FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. A prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Key Functionality AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from routine 12-lead ECG data. On-demand single-channel ECG measurement and irregular pulse monitoring for atrial fibrillation (AFib) detection.
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is an FDA-cleared AI algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs. Its primary utility is to aid in the early identification of patients at risk for heart failure. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including on-demand single-channel ECG and irregular pulse monitoring for AFib detection.
Bunkerhill ECG-EF is a software-only medical device that integrates seamlessly with Electronic Medical Records (EMR) or ECG Management Systems. It supports automated clinical workflows by analyzing routine 12-lead ECG data. The Verily Study Watch is a wearable device that collects data, which is then processed via cloud-based analytics, and a healthcare professional may prescribe it and recommend daily ECG rhythm capture and transmission for analysis.
Bunkerhill ECG-EF is designed to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%), aiding in the early identification of patients at risk for heart failure. The Verily Study Watch provides irregular pulse monitoring for atrial fibrillation (AFib) detection and on-demand single-channel ECG measurement, indicated for adult patients diagnosed with, or susceptible to developing, atrial fibrillation.
Bunkerhill ECG-EF analyzes data from routine 12-lead electrocardiograms (ECGs) that are already part of a patient's record, functioning as a non-invasive and rapid cardiac diagnostic tool. The Verily Study Watch is a wearable device that collects on-demand single-channel ECG measurements and other physiological data through its advanced sensors, requiring patient interaction to capture the ECG.
Bunkerhill ECG-EF is an AI algorithm for clinical reasoning and action, integrating with EHRs for use by healthcare providers, and is not a direct consumer product. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device intended for clinical research and healthcare use, not direct consumer sale.

Backers

Who funded each tool's parent company.

Study Watch with Irregular Pulse Monitor (Home)

AI Tool Finder
AI-powered search. Results may not be comprehensive.